Regulatory News

Filters

Date / Time Source Ticker Company Sector Market Cap Announcement
30Jun25 17:50 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Result of 2025 Annual General Meeting
17Jun25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - EACR 2025: Data demonstrating DNA dual analysis
17Jun25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - EACR 2025: Innovation in AR expression profiling
10Jun25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Novel discoveries into the biology of cancer
09Jun25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - POSTING OF ANNUAL REPORT AND NOTICE OF AGM
06Jun25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Board Changes
28May25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Preliminary Results
23May25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Notice of Results
28Apr25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
21Mar25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Results of Eisai Phase 2 pilot study
21Mar25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Issue of LTIP Options and Share Options
06Feb25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Novel findings using Parsortix
29Jan25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Analysis of CTC-DNA and ctDNA using Illumina assay
24Jan25 10:05 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix used in research paper from ETH Zurich
23Jan25 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Trading Update
13Dec24 08:43 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - HER2 presentation at SABCS
15Nov24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Research on HER2 assay kit showcased at AACR
15Nov24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix based PD-L1 assay showcased at AACR
13Nov24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - ANGLE presents two posters at EACR
11Nov24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix enriched CTC & ctDNA in NSCLC patients
17Oct24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Publication demonstrates CTC profiling potential
26Sep24 07:01 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - 100th publication supporting Parsortix system use
26Sep24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Half-year Report
23Sep24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Exclusive agreement for DNA NGS panel
19Sep24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Agreement with Recursion Pharmaceuticals
17Sep24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Notice of Interim Results and Webcast
22Aug24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Data supporting FDA approval published in Journal
01Aug24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Independent Parsortix study
18Jul24 10:08 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Standard form for notification of major holdings
12Jul24 15:38 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Standard form for notification of major holdings
11Jul24 15:07 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Result of 2024 Annual General Meeting
21Jun24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Result of open offer
18Jun24 14:41 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Posting of 2023 Annual Report & Notice of the AGM
11Jun24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix and assays being showcased at EACR 2024
06Jun24 16:37 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Publication of Circular
05Jun24 16:04 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Results of placing and subscription
05Jun24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Preliminary Results
05Jun24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Proposed Placing, Subscription and Open Offer
16May24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Study of ovarian cancer CTCs using Parsortix
03May24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - New commercial agreement with large pharma
24Apr24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - New commercial agreement with AstraZeneca
22Apr24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Potential utility in precision oncology
10Jan24 12:57 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Standard form for notification of major holdings
04Jan24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Breakthrough clinical results
02Jan24 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Broker Announcement
11Dec23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Trading and business update
09Nov23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - ANGLE notice of interim results
28Jun23 16:54 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Standard form for notification of major holdings
05Jun23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - ANGLE announces senior management appointments
25May23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Issue of LTIP Options and Share Options
09Feb23 14:44 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Director/PDMR shareholding
19Jan23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Appointment of Non-Executive Director
05Jan23 07:01 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Business Update
12Dec22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Issue of Equity
02Nov22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Issue of Equity
18Oct22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - First regional distribution agreement
30Sep22 17:30 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Issue of Equity
29Sep22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Interim Results
28Sep22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Results of Capital Raise
14Jul22 17:24 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Issue of Equity
29Jun22 16:35 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 RNS AGL:LON ANGLE plc Health £20.2m Angle PLC - Issue of Equity
Date / Time Source Company % Chg
30Jun25 17:50 RNS ANGLE plc -3.84%
Angle PLC - Result of 2025 Annual General Meeting
17Jun25 07:00 RNS ANGLE plc -3.84%
Angle PLC - EACR 2025: Data demonstrating DNA dual analysis
17Jun25 07:00 RNS ANGLE plc -3.84%
Angle PLC - EACR 2025: Innovation in AR expression profiling
10Jun25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Novel discoveries into the biology of cancer
09Jun25 07:00 RNS ANGLE plc -3.84%
Angle PLC - POSTING OF ANNUAL REPORT AND NOTICE OF AGM
06Jun25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Board Changes
28May25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Preliminary Results
23May25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Notice of Results
28Apr25 07:00 RNS ANGLE plc -3.84%
Angle PLC - RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
21Mar25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Results of Eisai Phase 2 pilot study
21Mar25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Issue of LTIP Options and Share Options
06Feb25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Novel findings using Parsortix
29Jan25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Analysis of CTC-DNA and ctDNA using Illumina assay
24Jan25 10:05 RNS ANGLE plc -3.84%
Angle PLC - Parsortix used in research paper from ETH Zurich
23Jan25 07:00 RNS ANGLE plc -3.84%
Angle PLC - Trading Update
13Dec24 08:43 RNS ANGLE plc -3.84%
Angle PLC - HER2 presentation at SABCS
15Nov24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Research on HER2 assay kit showcased at AACR
15Nov24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix based PD-L1 assay showcased at AACR
13Nov24 07:00 RNS ANGLE plc -3.84%
Angle PLC - ANGLE presents two posters at EACR
11Nov24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix enriched CTC & ctDNA in NSCLC patients
17Oct24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Publication demonstrates CTC profiling potential
26Sep24 07:01 RNS ANGLE plc -3.84%
Angle PLC - 100th publication supporting Parsortix system use
26Sep24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Half-year Report
23Sep24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Exclusive agreement for DNA NGS panel
19Sep24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Agreement with Recursion Pharmaceuticals
17Sep24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Notice of Interim Results and Webcast
22Aug24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Data supporting FDA approval published in Journal
01Aug24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Independent Parsortix study
18Jul24 10:08 RNS ANGLE plc -3.84%
Angle PLC - Standard form for notification of major holdings
12Jul24 15:38 RNS ANGLE plc -3.84%
Angle PLC - Standard form for notification of major holdings
11Jul24 15:07 RNS ANGLE plc -3.84%
Angle PLC - Result of 2024 Annual General Meeting
21Jun24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Result of open offer
18Jun24 14:41 RNS ANGLE plc -3.84%
Angle PLC - Posting of 2023 Annual Report & Notice of the AGM
11Jun24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix and assays being showcased at EACR 2024
06Jun24 16:37 RNS ANGLE plc -3.84%
Angle PLC - Publication of Circular
05Jun24 16:04 RNS ANGLE plc -3.84%
Angle PLC - Results of placing and subscription
05Jun24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Preliminary Results
05Jun24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Proposed Placing, Subscription and Open Offer
16May24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Study of ovarian cancer CTCs using Parsortix
03May24 07:00 RNS ANGLE plc -3.84%
Angle PLC - New commercial agreement with large pharma
24Apr24 07:00 RNS ANGLE plc -3.84%
Angle PLC - New commercial agreement with AstraZeneca
22Apr24 07:00 RNS ANGLE plc -3.84%
Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Potential utility in precision oncology
10Jan24 12:57 RNS ANGLE plc -3.84%
Angle PLC - Standard form for notification of major holdings
04Jan24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Breakthrough clinical results
02Jan24 07:00 RNS ANGLE plc -3.84%
Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Broker Announcement
11Dec23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00 RNS ANGLE plc -3.84%
Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Trading and business update
09Nov23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00 RNS ANGLE plc -3.84%
Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00 RNS ANGLE plc -3.84%
Angle PLC - ANGLE notice of interim results
28Jun23 16:54 RNS ANGLE plc -3.84%
Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24 RNS ANGLE plc -3.84%
Angle PLC - Standard form for notification of major holdings
05Jun23 07:00 RNS ANGLE plc -3.84%
Angle PLC - ANGLE announces senior management appointments
25May23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04 RNS ANGLE plc -3.84%
Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00 RNS ANGLE plc -3.84%
Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00 RNS ANGLE plc -3.84%
Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Issue of LTIP Options and Share Options
09Feb23 14:44 RNS ANGLE plc -3.84%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:01 RNS ANGLE plc -3.84%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 RNS ANGLE plc -3.84%
Angle PLC - Business Update
12Dec22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 RNS ANGLE plc -3.84%
Angle PLC - Issue of Equity
02Nov22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 RNS ANGLE plc -3.84%
Angle PLC - Issue of Equity
18Oct22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 RNS ANGLE plc -3.84%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 RNS ANGLE plc -3.84%
Angle PLC - First regional distribution agreement
30Sep22 17:30 RNS ANGLE plc -3.84%
Angle PLC - Issue of Equity
29Sep22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Interim Results
28Sep22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 RNS ANGLE plc -3.84%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 RNS ANGLE plc -3.84%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 07:00 RNS ANGLE plc -3.84%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 RNS ANGLE plc -3.84%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Results of Capital Raise
14Jul22 17:24 RNS ANGLE plc -3.84%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 RNS ANGLE plc -3.84%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 RNS ANGLE plc -3.84%
Angle PLC - Issue of Equity
29Jun22 16:35 RNS ANGLE plc -3.84%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 RNS ANGLE plc -3.84%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 RNS ANGLE plc -3.84%
Angle PLC - Issue of Equity
Date / Time Company % Chg
30Jun25 17:50 ANGLE plc -3.84%
Angle PLC - Result of 2025 Annual General Meeting
17Jun25 07:00 ANGLE plc -3.84%
Angle PLC - EACR 2025: Data demonstrating DNA dual analysis
17Jun25 07:00 ANGLE plc -3.84%
Angle PLC - EACR 2025: Innovation in AR expression profiling
10Jun25 07:00 ANGLE plc -3.84%
Angle PLC - Novel discoveries into the biology of cancer
09Jun25 07:00 ANGLE plc -3.84%
Angle PLC - POSTING OF ANNUAL REPORT AND NOTICE OF AGM
06Jun25 07:00 ANGLE plc -3.84%
Angle PLC - Board Changes
28May25 07:00 ANGLE plc -3.84%
Angle PLC - Preliminary Results
23May25 07:00 ANGLE plc -3.84%
Angle PLC - Notice of Results
28Apr25 07:00 ANGLE plc -3.84%
Angle PLC - RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
21Mar25 07:00 ANGLE plc -3.84%
Angle PLC - Results of Eisai Phase 2 pilot study
21Mar25 07:00 ANGLE plc -3.84%
Angle PLC - Issue of LTIP Options and Share Options
06Feb25 07:00 ANGLE plc -3.84%
Angle PLC - Novel findings using Parsortix
29Jan25 07:00 ANGLE plc -3.84%
Angle PLC - Analysis of CTC-DNA and ctDNA using Illumina assay
24Jan25 10:05 ANGLE plc -3.84%
Angle PLC - Parsortix used in research paper from ETH Zurich
23Jan25 07:00 ANGLE plc -3.84%
Angle PLC - Trading Update
13Dec24 08:43 ANGLE plc -3.84%
Angle PLC - HER2 presentation at SABCS
15Nov24 07:00 ANGLE plc -3.84%
Angle PLC - Research on HER2 assay kit showcased at AACR
15Nov24 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix based PD-L1 assay showcased at AACR
13Nov24 07:00 ANGLE plc -3.84%
Angle PLC - ANGLE presents two posters at EACR
11Nov24 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix enriched CTC & ctDNA in NSCLC patients
17Oct24 07:00 ANGLE plc -3.84%
Angle PLC - Publication demonstrates CTC profiling potential
26Sep24 07:01 ANGLE plc -3.84%
Angle PLC - 100th publication supporting Parsortix system use
26Sep24 07:00 ANGLE plc -3.84%
Angle PLC - Half-year Report
23Sep24 07:00 ANGLE plc -3.84%
Angle PLC - Exclusive agreement for DNA NGS panel
19Sep24 07:00 ANGLE plc -3.84%
Angle PLC - Agreement with Recursion Pharmaceuticals
17Sep24 07:00 ANGLE plc -3.84%
Angle PLC - Notice of Interim Results and Webcast
22Aug24 07:00 ANGLE plc -3.84%
Angle PLC - Data supporting FDA approval published in Journal
01Aug24 07:00 ANGLE plc -3.84%
Angle PLC - Independent Parsortix study
18Jul24 10:08 ANGLE plc -3.84%
Angle PLC - Standard form for notification of major holdings
12Jul24 15:38 ANGLE plc -3.84%
Angle PLC - Standard form for notification of major holdings
11Jul24 15:07 ANGLE plc -3.84%
Angle PLC - Result of 2024 Annual General Meeting
21Jun24 07:00 ANGLE plc -3.84%
Angle PLC - Result of open offer
18Jun24 14:41 ANGLE plc -3.84%
Angle PLC - Posting of 2023 Annual Report & Notice of the AGM
11Jun24 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix and assays being showcased at EACR 2024
06Jun24 16:37 ANGLE plc -3.84%
Angle PLC - Publication of Circular
05Jun24 16:04 ANGLE plc -3.84%
Angle PLC - Results of placing and subscription
05Jun24 07:00 ANGLE plc -3.84%
Angle PLC - Preliminary Results
05Jun24 07:00 ANGLE plc -3.84%
Angle PLC - Proposed Placing, Subscription and Open Offer
16May24 07:00 ANGLE plc -3.84%
Angle PLC - Study of ovarian cancer CTCs using Parsortix
03May24 07:00 ANGLE plc -3.84%
Angle PLC - New commercial agreement with large pharma
24Apr24 07:00 ANGLE plc -3.84%
Angle PLC - New commercial agreement with AstraZeneca
22Apr24 07:00 ANGLE plc -3.84%
Angle PLC - US and EU patents for innovative CellKeep™ slide
08Apr24 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix HER2 assay showcased at AACR 2024
22Mar24 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix at European breast cancer conference
22Jan24 07:00 ANGLE plc -3.84%
Angle PLC - Potential utility in precision oncology
10Jan24 12:57 ANGLE plc -3.84%
Angle PLC - Standard form for notification of major holdings
04Jan24 07:00 ANGLE plc -3.84%
Angle PLC - Breakthrough clinical results
02Jan24 07:00 ANGLE plc -3.84%
Angle PLC - Contract announcement with Eisai Inc.
11Dec23 07:00 ANGLE plc -3.84%
Angle PLC - Broker Announcement
11Dec23 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix unlocks opportunities for drug discovery
05Dec23 07:00 ANGLE plc -3.84%
Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
09Nov23 07:00 ANGLE plc -3.84%
Angle PLC - Trading and business update
09Nov23 07:00 ANGLE plc -3.84%
Angle PLC - Launch of PD-L1 test to support cancer studies
25Oct23 07:00 ANGLE plc -3.84%
Angle PLC - Supporting characterisation of CTCs in HNSCC
03Oct23 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix outperforms standard for DTC harvest
29Sep23 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix system showcased at ACTC conference
07Sep23 07:00 ANGLE plc -3.84%
Angle PLC - Interim Results for the period ended 30 June 2023
04Sep23 07:00 ANGLE plc -3.84%
Angle PLC - ANGLE launch of Portrait Flex assay
15Aug23 07:00 ANGLE plc -3.84%
Angle PLC - ANGLE notice of interim results
28Jun23 16:54 ANGLE plc -3.84%
Angle PLC - Result of 2023 Annual General Meeting
27Jun23 12:24 ANGLE plc -3.84%
Angle PLC - Standard form for notification of major holdings
05Jun23 07:00 ANGLE plc -3.84%
Angle PLC - ANGLE announces senior management appointments
25May23 07:00 ANGLE plc -3.84%
Angle PLC - Pharma services contract with Artios Pharma
22May23 07:00 ANGLE plc -3.84%
Angle PLC - Board change - appointment of new Chairman
21Apr23 12:04 ANGLE plc -3.84%
Angle PLC - ANGLE presentation via Investor Meet Company
21Apr23 07:00 ANGLE plc -3.84%
Angle PLC - Results for the year ended 31 December 2022
19Apr23 07:00 ANGLE plc -3.84%
Angle PLC - ANGLE announces partnership with BioView
17Apr23 07:00 ANGLE plc -3.84%
Angle PLC - ANGLE Parsortix poster presented at AACR 2023
13Apr23 07:00 ANGLE plc -3.84%
Angle PLC - Pharma Services Contract with Crescendo Biologics
03Apr23 07:00 ANGLE plc -3.84%
Angle PLC - Notice of Preliminary Results and Webcast
10Mar23 07:00 ANGLE plc -3.84%
Angle PLC - Issue of LTIP Options and Share Options
09Feb23 14:44 ANGLE plc -3.84%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00 ANGLE plc -3.84%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:01 ANGLE plc -3.84%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00 ANGLE plc -3.84%
Angle PLC - Business Update
12Dec22 07:00 ANGLE plc -3.84%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30 ANGLE plc -3.84%
Angle PLC - Issue of Equity
02Nov22 07:00 ANGLE plc -3.84%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00 ANGLE plc -3.84%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15 ANGLE plc -3.84%
Angle PLC - Issue of Equity
18Oct22 07:00 ANGLE plc -3.84%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23 ANGLE plc -3.84%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00 ANGLE plc -3.84%
Angle PLC - First regional distribution agreement
30Sep22 17:30 ANGLE plc -3.84%
Angle PLC - Issue of Equity
29Sep22 07:00 ANGLE plc -3.84%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00 ANGLE plc -3.84%
Angle PLC - Interim Results
28Sep22 07:00 ANGLE plc -3.84%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00 ANGLE plc -3.84%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30 ANGLE plc -3.84%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00 ANGLE plc -3.84%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00 ANGLE plc -3.84%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 07:00 ANGLE plc -3.84%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00 ANGLE plc -3.84%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00 ANGLE plc -3.84%
Angle PLC - Results of Capital Raise
14Jul22 17:24 ANGLE plc -3.84%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23 ANGLE plc -3.84%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30 ANGLE plc -3.84%
Angle PLC - Issue of Equity
29Jun22 16:35 ANGLE plc -3.84%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00 ANGLE plc -3.84%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24 ANGLE plc -3.84%
Angle PLC - Issue of Equity